Update of Critical Illness Neuromyopathy
10.46518/kjnmd.2024.16.2.21
- Author:
Soo-Hyun PARK
1
;
Nam-Hee KIM
Author Information
1. Department of Neurology, SoonChunHyang University Hospital, Seoul, Korea
- Publication Type:Review Article
- From:
Korean Journal of Neuromuscular Disorders
2024;16(2):21-26
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Critical illness neuromyopathy (CINM) is a common yet frequently overlooked complication in intensive care units (ICU). CINM often results in prolonged ventilator dependence and persistent limb weakness, significantly impacting patient recovery and long-term quality of life. CINM can be categorized into two primary subtypes: critical illness polyneuropathy (CIP) and critical illness myopathy (CIM). These conditions frequently arise in the context of severe sepsis, multiple organ failure, or as adverse effects of certain medications used in the ICU. This review aims to provide a concise overview of CINM, focusing on its pathophysiology, diagnostic approaches, and current clinical management strategies.
